← All trials
NCT05170009
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 22, 2022
- Primary completion
- Aug 31, 2023
- Completion date
- Oct 31, 2023
- First posted
- Dec 27, 2021
- Last posted
- Jun 28, 2022
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Cornell UniversityLead sponsor
- GenentechCollaborator
- Cornell UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.